• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 27, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Third Course of Stereotactic Radiotherapy Shown Safe in Spinal Osteosarcoma Case

by
October 27, 2026
in Health
Reading Time: 3 mins read
0
Third Course of Stereotactic Radiotherapy Shown Safe in Spinal Osteosarcoma Case

Third Course of Stereotactic Radiotherapy Shown Safe in Spinal Osteosarcoma Case

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Doctors in Warsaw have reported what they describe as the first documented case of a second reirradiation with stereotactic body radiotherapy (SBRT) in a patient with metastatic osteosarcoma. The case report, accepted for publication in Frontiers in Oncology in the Radiation Oncology section, details how a third course of precisely targeted radiotherapy to the spine achieved a partial response without any acute adverse events, offering a rare data point in an area where evidence is extremely scarce. The patient, treated at the Maria Sklodowska-Curie National Research Institute of Oncology, had already undergone multiple surgical interventions in the cervical and thoracic spine and three lines of chemotherapy before showing local progression in the cervicothoracic region of the spine.

The multidisciplinary team then delivered a third SBRT course to the oligoprogressive spinal lesions. SBRT has emerged in recent years as a promising approach for vertebral metastases generally, achieving high local control rates with a favorable safety profile. Despite that growing trend, the authors note that evidence on spinal reirradiation with SBRT remains limited, and data are especially sparse for radioresistant histologies such as osteosarcoma, which is why this single case carries weight for the field.

The reported outcome was a partial response at the treated spinal sites, with no acute adverse events recorded. The authors conclude that even a third SBRT course can yield clinical benefit and be executed safely, provided it is delivered according to proper technical regimens and critical organ sparing strategies. They emphasize that this applies to a carefully selected group of patients, and that the finding comes from a single case rather than a controlled study.

The report also underscores the role of multidisciplinary decision-making in sarcoma care. For the field, the case adds to a small but growing literature on repeat stereotactic irradiation of the spine. Preliminary studies cited by the authors, together with this report, suggest the approach can be useful, effective and safe in selected patients, including those with histologies traditionally considered difficult to treat with radiotherapy.

The authors caution, however, that the evidence base is still preliminary. As a single-patient case report, the study's conclusions rest on one individual's outcome, and the authors themselves present it as a signal rather than a definitive result. Nevertheless, they present it as evidence that repeated SBRT to spinal metastases, even a third course, can be considered in carefully selected patients with radioresistant tumors, pending the larger datasets that will be needed to confirm who benefits most.

The work was carried out by a team from the Department of Soft Tissue/Bone Sarcoma and Melanoma, the Department of Pathology and the Department of Radiotherapy I at the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, and the authors state that all claims expressed in the article are solely their own and do not necessarily represent those of their affiliated organizations or the publisher.

Subject of Research: Stereotactic reirradiation of oligoprogressive spinal metastases from dedifferentiated osteosarcoma

Article Title: Multidisciplinary approach with stereotactic reirradiation to oligoprogressive spinal metastases from dedifferentiated osteosarcoma: a case report

Article References: Moskwa, A., Chmiel, P., Kozak, K., Wągrodzki, M., Rutkowski, P., & Spałek, M. (2026). Multidisciplinary approach with stereotactic reirradiation to oligoprogressive spinal metastases from dedifferentiated osteosarcoma: a case report. Frontiers in Oncology, 16, Article 1929146. https://doi.org/10.3389/fonc.2026.1929146

Image Credits: AI Generated

DOI: 10.3389/fonc.2026.1929146

Keywords: osteosarcoma, spinal metastases, SBRT, reirradiation, oligoprogression, case report, radiation oncology, spinal cord sparing, multidisciplinary care, sarcoma, Multidisciplinary, approach

News Source: Nathaniel Bowman. (October 27, 2026). Third Course of Stereotactic Radiotherapy Shown Safe in Spinal Osteosarcoma Case. Scienmag.

Tags: approachcase reportMultidisciplinarymultidisciplinary careoligoprogressionOsteosarcomaradiation oncologyreirradiationsarcomaSBRTspinal cord sparingspinal metastases
Share12Tweet7Share2ShareShareShare1

Related Posts

Achalasia Mistaken for Acid Reflux for 26 Years Before Surgery Restored Swallowing

Achalasia Mistaken for Acid Reflux for 26 Years Before Surgery Restored Swallowing

October 27, 2026
Research report: Enhancing student confidence and preparedness in pharmacology: a virtual pre-laboratory approach

Research report: Enhancing student confidence and preparedness in pharmacology: a virtual pre-laboratory approach

October 27, 2026

Research report: In vivo blood and ex vivo brain solid-phase microextraction coupled with LC-MS/MS for mapping unbound cannabidiol, phase I metabolites, and endocannabinoid tone

October 27, 2026

Traditional Herb Compound Oxymatrine Shows Promise Against Psoriasis by Taming a Key Immune Signaling Pathway

October 27, 2026

POPULAR NEWS

  • Body Image Distress Rises in Final Months for Pancreatic Cancer Patients of Both Sexes

    Body Image Distress Rises in Final Months for Pancreatic Cancer Patients of Both Sexes

    29 shares
    Share 12 Tweet 7
  • Botanists complete first full flora of Empoli, revealing heavy alien invasion

    29 shares
    Share 12 Tweet 7
  • Research report: SLAM Project – Long-Term Ecological Study of the Impacts of Climate Change in the natural forest of Azores: VII – Long-term arthropod monitoring in Graciosa Island

    29 shares
    Share 12 Tweet 7
  • Gemcitabine-Fused microRNA Shows Promise Against Chemoresistant Colorectal Cancer in Preclinical Models

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Body Image Distress Rises in Final Months for Pancreatic Cancer Patients of Both Sexes

Botanists complete first full flora of Empoli, revealing heavy alien invasion

Research report: SLAM Project – Long-Term Ecological Study of the Impacts of Climate Change in the natural forest of Azores: VII – Long-term arthropod monitoring in Graciosa Island

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.